KORU Medical Systems, Inc.

KRMD Healthcare Medical Instruments & Supplies

KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

3.00 0.03 −0.99%
Market cap
$139.9M
P/E
0.0×
Fwd P/E
−89.3×
Dividend yield
—
F-score
5/9
Altman Z
14.46
Beneish M
−2.90
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
4.29 4.63 6.52 4.53
P/FCF ratio
775.14 1,645.82 0.00 0.00
P/Operating CF
895.66 13,625.60 245.11 2,707.87
P/B ratio
10.72 11.84 15.74 10.76
EV/Sales
4.11 4.43 6.31 4.32
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
742.24 1,574.16 (532.53) (992.05)
Current Ratio
2.72 2.33 2.44 2.48
Net Debt/EBITDA
(9.82) 13.07 23.90 12.59
Debt/Equity
0.00 0.00 0.00 0.01
Earnings Yield
(1.06%) (1.26%) (1.11%) (2.21%)
Free Cash Flow Yield
0.13% 0.06% (0.18%) (0.10%)
Free Cash Flow per Share
(0.01) 0.00 0.01 0.00
Book value per Share
0.39 0.37 0.37 0.36
Free Cash Flow
(0.36) (0.08) 0.67 0.01
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates